CeriBell, Inc. Common Stock (CBLL) Stock Price
CBLLStock
$25.04+92.76%52W
Market Cap$960.99M
P/E—
PEG Ratio—
Div yield—
Beta0.83
CBLL Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)18.18%
Price vs S&P 500 (4W)4.58%
VGM Score62.29
CBLL Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.46 | -$0.40 | +11.94%(+$0.05) | |
| Q1 2026 | -$0.39 | -$0.38 | +3.62%(+$0.01) | |
| Q4 2025 | -$0.41 | -$0.36 | +12.65%(+$0.05) | |
| Q3 2025 | -$0.41 | -$0.37 | +10.63%(+$0.04) | |
| Q2 2025 | -$0.40 | -$0.38 | +4.35%(+$0.02) |
CBLL Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.43
4.43
4.43
4.43
Industry Peers — Electromedical Equipment(31)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
CBLLCeriBell, Inc. Common Stock | F | A | A | 9.4x | — | 88.9% | -68.6% | $25.04 |
| MDTMedtronic plc | B | C | B | 3.2x | 3.8% | 65.7% | 18.1% | $94.75 |
| ITGRInteger Holdings Corporation | C | C | A | 2.3x | 11.6% | 26.1% | 9.7% | $126.70 |
| LIVNLivaNova PLC Ordinary Shares | C | B | B | 2.9x | 8.2% | 68.1% | 12.5% | $77.58 |
| TMDXTransMedics Group, Inc. Common Stock | C | B | D | 3.7x | 88.2% | 58.7% | 12.2% | $70.78 |
| AXGNAxogen, Inc. Common Stock | F | B | B | 8.1x | 14.9% | 74.6% | -11.8% | $34.62 |
| BLFSBioLife Solutions Inc. | F | C | A | 18.4x | 14.9% | 63.9% | 2.9% | $38.61 |
| CNMDCONMED Corporation | B | C | B | 1.0x | 9.8% | 55.8% | 8.0% | $46.72 |
| INMDInMode Ltd. Ordinary Shares | A | D | C | 2.2x | 12.4% | 76.5% | 18.5% | $14.16 |
| CVCapsoVision, Inc. Common Stock | F | D | B | 25.0x | — | 50.9% | -217.1% | $6.53 |
| ELMDElectromed, Inc. | C | B | C | 3.1x | 15.6% | 78.5% | 18.8% | $27.42 |
About CeriBell, Inc. Common Stock
CeriBell Inc. develops portable point-of-care EEG systems for rapid neurological diagnosis in acute care settings. The company's Ceribell System combines proprietary hardware with AI algorithms to address critical diagnostic needs. Products include Point-of-Care EEG devices, Clarity analytics software, and the EEG Portal platform.